日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up

更正：Brentuximab vedotin联合化疗一线治疗系统性间变性大细胞淋巴瘤：ECHELON-2研究5年随访亚组分析

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01432-4
Domingo-Domènech, Eva; Pro, Barbara; Illidge, Tim; Horwitz, Steven; Trumper, Lorenz; Iyer, Swami; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob Haaber; Kim, Won-Seog; Feldman, Tatyana; Choi, Ilseung; Gritti, Giuseppe; Belada, David; Shustov, Andrei; Illes, Arpad; Zinzani, Pier Luigi; Hüttmann, Andreas; Trneny, Marek; Le Gouill, Steven; Jagadeesh, Deepa; Friedberg, Jonathan W; Little, Meredith; Dong, Cassie; Fanale, Michelle; Fenton, Keenan; Savage, Kerry J
细胞生物学
淋巴瘤
发表日期：2026
文献求助 收藏

Astrocytes Control Norepinephrine Signaling in the Brain

星形胶质细胞控制大脑中的去甲肾上腺素信号传导

期刊:Neuroscience Bulletin
影响因子:5.8
doi:10.1007/s12264-025-01551-9
Xiong, Hai-Yun; Illes, Peter; Tang, Yong
胶质细胞
信号转导
神经科学
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Serpine2-Lrp1 and CD39-A(3)AR Intercellular Signalling Pathways: Novel Therapeutic Targets for Vascular Dementia

Serpine2-Lrp1 和 CD39-A(3)AR 细胞间信号通路：血管性痴呆的新型治疗靶点

期刊:Neuroscience Bulletin
影响因子:5.8
doi:10.1007/s12264-025-01560-8
Ran, Xiao-Feng; Illes, Peter; Tang, Yong
信号转导
细胞生物学
CD3
CD39
发表日期：2026
文献求助 收藏

Canadian copyright protections for neurodata: ethical and legal implications

加拿大对神经数据的版权保护：伦理和法律影响

期刊:Journal of Law and the Biosciences
影响因子:2.4
doi:10.1093/jlb/lsag008
Lavelle, Kyrstin; Magistro Nadler, Reina; Gunning, Margot; Reynolds, Graham J; Illes, Judy
发表日期：2026
文献求助 收藏

Relapse-related outcomes in the Danish population-based AQP4- antibody seropositive neuromyelitis optica spectrum disorder cohort

丹麦基于人群的AQP4抗体血清阳性视神经脊髓炎谱系障碍队列中与复发相关的结局

期刊:Neurological Sciences
影响因子:2.4
doi:10.1007/s10072-025-08754-y
Mamoei, Sepehr; Möller, Sören; Magyari, Melinda; Sellebjerg, Finn; Frederiksen, Jette L; Svendsen, Kristina B; Saleem, Rasha; Søndergaard, Helle B; Nilsson, Anna C; Papp, Viktoria; Illes, Zsolt
AQP4
神经科学
发表日期：2026
文献求助 收藏

In tribute to Francesco Di Virgilio, a great scientist and a wonderful friend

谨以此文缅怀伟大的科学家和挚友弗朗切斯科·迪·维吉利奥

期刊:Purinergic Signalling
影响因子:2.4
doi:10.1007/s11302-026-10135-9
Falzoni, Simonetta; Giuliani, Anna Lisa; Adinolfi, Elena; Coutinho-Silva, Robson; Illes, Peter; Robson, Simon C; Tang, Yong; Ulrich, Henning; Kennedy, Charles
发表日期：2026
文献求助 收藏

P2X7 receptor mediates the anti-tumor effect of running on cervical cancer in mice

P2X7受体介导跑步对小鼠宫颈癌的抗肿瘤作用

期刊:Purinergic Signalling
影响因子:2.4
doi:10.1007/s11302-026-10143-9
Xiong, Hai-Yun; Li, Rui; Hu, Xiu-Min; Zhang, Yi; Rubini, Patrizia; Illes, Peter; Tang, Yong
宫颈癌
信号转导
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

A National Danish Effectiveness Study of Ocrelizumab Versus Natalizumab in Multiple Sclerosis

丹麦一项全国性奥克瑞珠单抗与那他珠单抗治疗多发性硬化症的疗效研究

期刊:European Journal of Neurology
影响因子:
doi:10.1111/ene.70507
Maersk-Moller, Camilla; Pontieri, Luigi; Stilund, Morten Leif Munding; Christensen, Jeppe Romme; Storr, Lars Kristian; Hansen, Victoria; Schäfer, Jakob; Weglewski, Arkadiusz; Romani, Katerina Quinto; Jensen, Henrik Boye; Illes, Zsolt; Papp, Victoria; Sejbaek, Tobias; Poulsen, Mai Bang; Kant, Matthias; Torring, Caroline Winther; Sellebjerg, Finn; Magyari, Melinda
神经科学
多发性硬化症
发表日期：2026
文献求助 收藏

Event-free survival in early polycythemia vera patients correlates with molecular response to ropeginterferon alfa-2b or hydroxyurea/best available therapy (PROUD-PV/CONTINUATION-PV)

早期真性红细胞增多症患者的无事件生存期与对罗培南干扰素α-2b或羟基脲/最佳可用疗法的分子反应相关（PROUD-PV/CONTINUATION-PV）

期刊:Hemasphere
影响因子:14.6
doi:10.1002/hem3.70137
Kiladjian, Jean-Jacques; Klade, Christoph; Georgiev, Pencho; Krochmalczyk, Dorota; Gercheva-Kyuchukova, Liana; Egyed, Miklos; Dulicek, Petr; Illes, Arpad; Pylypenko, Halyna; Sivcheva, Lylia; Mayer, Jiří; Yablokova, Vera; Krejcy, Kurt; Empson, Victoria; Hasselbalch, Hans C; Kralovics, Robert; Gisslinger, Heinz
细胞生物学
红细胞
发表日期：2025
文献求助 收藏

Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up

Brentuximab vedotin联合化疗一线治疗系统性间变性大细胞淋巴瘤：ECHELON-2研究5年随访亚组分析

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01329-2
Domingo-Domènech, Eva; Pro, Barbara; Illidge, Tim; Horwitz, Steven; Trumper, Lorenz; Iyer, Swami; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob Haaber; Kim, Won-Seog; Feldman, Tatyana; Choi, Ilseung; Gritti, Giuseppe; Belada, David; Shustov, Andrei; Illes, Arpad; Zinzani, Pier Luigi; Hüttmann, Andreas; Trneny, Marek; Le Gouill, Steven; Jagadeesh, Deepa; Friedberg, Jonathan W; Little, Meredith; Dong, Cassie; Fanale, Michelle; Fenton, Keenan; Savage, Kerry J
细胞生物学
淋巴瘤
发表日期：2025
文献求助 收藏